• Curr Opin Oncol · Nov 2006

    Review

    Epidermal growth factor receptor pathway targeted therapy in patients with aerodigestive malignancies.

    • Jyoti D Patel.
    • Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois 60611, USA. jd-patel@northwestern.edu
    • Curr Opin Oncol. 2006 Nov 1; 18 (6): 609-14.

    Purpose Of ReviewThe present review will describe progress in the utilization of epidermal growth factor receptor (EGFR) inhibitors in the treatment of nonsmall-cell lung cancer and the treatment of squamous cell carcinoma of the head and neck. Recent findings regarding clinical activity as well as markers associated with sensitivity to these agents will be reviewed.Recent FindingsThe EGFR pathway plays a crucial role in human carcinogenesis by contributing to relevant processes in tumor development and progression, including cell proliferation, differentiation, regulation of apoptotic cell death, metastatic potential, and blood vessel formation. Anti-EGFR agents include monoclonal antibodies that target the EGFR extracellular receptor domain, and small molecule tyrosine kinase inhibitors that target the EGFR intracellular domain. Both strategies have demonstrated encouraging results as monotherapies and in combination with chemotherapy and radiotherapy in areodigestive malignancies.SummaryThese dramatic successes have led to further clinical studies of EGFR targeted therapy in aerodigestive malignancies, making a significant impact on the clinical care of patients with nonsmall-cell lung cancer and squamous cell carcinoma of the head and neck.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…